Upcoming decision An FDA advisory committee is expected to review a further batch of compounding-list peptides — decision expected Feb 2027. What this means →

The evidence, not the hype

Look up any peptide.

One search for what the published research actually reports — sourced, neutral, and with nothing for sale.

Muscle & recovery Gut Skin Metabolic Hormonal Heart Immune Tendon & tissue

Featured dossier 4 sources indexed

BPC-157

Synthetic peptide studied in animal models of connective-tissue and gastrointestinal injury.

MusculoskeletalGastrointestinalConnective tissue

Read the dossier →

compounds

sources

for sale

Start here

How peptides are regulated → Legal status, mapped → This week’s regulation updates → Viral claims, fact-checked →

The library

9 compounds

BPC-157

Synthetic peptide studied in animal models of connective-tissue and gastrointestinal injury.

Musculoskeletal · Gastrointestinal · Connective tissue 4 sources

Thymosin Beta-4

TB-500

Naturally occurring peptide investigated in cell-migration and cardiovascular research.

Musculoskeletal · Cardiovascular · Connective tissue 3 sources

Copper Tripeptide-1

GHK-Cu

Copper-binding tripeptide examined in dermatological and wound-model studies.

Dermatological · Connective tissue 2 sources

Semaglutide

GLP-1 receptor agonist with an extensive metabolic and endocrine clinical literature.

Metabolic · Endocrine 3 sources

Thymosin Alpha-1

Tα1

Immune-signaling peptide studied in immunological contexts.

Immune 3 sources

CJC-1295

Growth-hormone-releasing analog. Corpus entry planned.

Endocrine · Metabolic 3 sources

Ipamorelin

Selective GH secretagogue. Corpus entry planned.

Endocrine · Metabolic 2 sources

Melanotan II

MT-II

Melanocortin analog studied in dermatological research. Corpus entry planned.

Dermatological 3 sources

NAD+

Cellular coenzyme sold in the longevity market as precursors (NMN, NR) and IV drips — not a peptide.

Metabolic 6 sources